Litts Drug Eruption & Reaction Database - Presented by CRC Press

The most comprehensive database on adverse drug reactions for our profession.David Adams MD


Log in
In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Continue
Menu
Login
  • Home
  • About About
    • About the Database
    • About the Book
    • Related Products
    • About Dr Litt
    • About Dr Shear
  • Alerts
  • Litt’s App
  • Contact Us
  • Help
  • Subscribe Subscribe
    • Individual Subscription
    • Institutional Subscription

Levamisole comment watch save

  • TRADE NAMES: Ascaridil; Decaris; Detrax 40; Ergamisol (Janssen); Ketrax; Solaskil; Termizole
  • INDICATIONS: Susceptible helmintic organism infections, colorectal carcinoma
  • CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor), Immunomodulator
  • HALF-LIFE: 2–6 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Alcohol, Aldesleukin
  • See adverse reactions attributed to class:

    Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor)

    Immunomodulator

Levamisole is a known contaminant of cocaine.

This drug has been withdrawn in Canada and the USA.

Please login to view the rest of this drug profile.

Page last updated 10/09/2024

Saved Searches Watched Drugs
Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone!

If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top
  • Help
  • Terms & Conditions
  • Privacy
  • Disclaimer
  • Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.